Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/govt-bans-common-painkiller-21533/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/govt-bans-common-painkiller-21533/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/govt-bans-common-painkiller-21533/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/govt-bans-common-painkiller-21533/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f045b0e3d2e-trace').style.display = (document.getElementById('cakeErr67f045b0e3d2e-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f045b0e3d2e-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f045b0e3d2e-code').style.display = (document.getElementById('cakeErr67f045b0e3d2e-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f045b0e3d2e-context').style.display = (document.getElementById('cakeErr67f045b0e3d2e-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f045b0e3d2e-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f045b0e3d2e-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21386,
		&#039;title&#039; =&gt; &#039;Govt bans common painkiller&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 12 June, 2013, http://www.telegraphindia.com/1130612/jsp/nation/story_16998338.jsp#.UbgQpNjcjco&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;govt-bans-common-painkiller-21533&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21533,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21386,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Govt bans common painkiller&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21386,
	&#039;title&#039; =&gt; &#039;Govt bans common painkiller&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 12 June, 2013, http://www.telegraphindia.com/1130612/jsp/nation/story_16998338.jsp#.UbgQpNjcjco&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;govt-bans-common-painkiller-21533&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21533,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21386
$metaTitle = &#039;LATEST NEWS UPDATES | Govt bans common painkiller&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/govt-bans-common-painkiller-21533.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Govt bans common painkiller | Im4change.org</title>
    <meta name="description" content="
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Govt bans common painkiller</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><br />The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.</p><p align="justify">The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.</p><p align="justify">The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.</p><p align="justify">Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.</p><p align="justify">The European Medicines Agency had recommended DPPP's withdrawal across the European Union in 2009, saying the drug's risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.</p><p align="justify">Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &quot;It's truly heartening to hear the government has acted to ban this drug - better late than never,&quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.</p><p align="justify">Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.</p><p align="justify">When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &quot;We could only say - ask the government,&quot; one doctor said.</p><p align="justify">In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.</p><p align="justify">&quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&quot; one senior doctor in a government hospital said.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f045b0e3d2e-trace').style.display = (document.getElementById('cakeErr67f045b0e3d2e-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f045b0e3d2e-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f045b0e3d2e-code').style.display = (document.getElementById('cakeErr67f045b0e3d2e-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f045b0e3d2e-context').style.display = (document.getElementById('cakeErr67f045b0e3d2e-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f045b0e3d2e-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f045b0e3d2e-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21386,
		&#039;title&#039; =&gt; &#039;Govt bans common painkiller&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 12 June, 2013, http://www.telegraphindia.com/1130612/jsp/nation/story_16998338.jsp#.UbgQpNjcjco&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;govt-bans-common-painkiller-21533&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21533,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21386,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Govt bans common painkiller&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21386,
	&#039;title&#039; =&gt; &#039;Govt bans common painkiller&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 12 June, 2013, http://www.telegraphindia.com/1130612/jsp/nation/story_16998338.jsp#.UbgQpNjcjco&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;govt-bans-common-painkiller-21533&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21533,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21386
$metaTitle = &#039;LATEST NEWS UPDATES | Govt bans common painkiller&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/govt-bans-common-painkiller-21533.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Govt bans common painkiller | Im4change.org</title>
    <meta name="description" content="
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Govt bans common painkiller</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><br />The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.</p><p align="justify">The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.</p><p align="justify">The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.</p><p align="justify">Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.</p><p align="justify">The European Medicines Agency had recommended DPPP's withdrawal across the European Union in 2009, saying the drug's risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.</p><p align="justify">Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &quot;It's truly heartening to hear the government has acted to ban this drug - better late than never,&quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.</p><p align="justify">Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.</p><p align="justify">When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &quot;We could only say - ask the government,&quot; one doctor said.</p><p align="justify">In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.</p><p align="justify">&quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&quot; one senior doctor in a government hospital said.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f045b0e3d2e-trace').style.display = (document.getElementById('cakeErr67f045b0e3d2e-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f045b0e3d2e-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f045b0e3d2e-code').style.display = (document.getElementById('cakeErr67f045b0e3d2e-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f045b0e3d2e-context').style.display = (document.getElementById('cakeErr67f045b0e3d2e-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f045b0e3d2e-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f045b0e3d2e-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21386,
		&#039;title&#039; =&gt; &#039;Govt bans common painkiller&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 12 June, 2013, http://www.telegraphindia.com/1130612/jsp/nation/story_16998338.jsp#.UbgQpNjcjco&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;govt-bans-common-painkiller-21533&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21533,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21386,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Govt bans common painkiller&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21386,
	&#039;title&#039; =&gt; &#039;Govt bans common painkiller&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 12 June, 2013, http://www.telegraphindia.com/1130612/jsp/nation/story_16998338.jsp#.UbgQpNjcjco&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;govt-bans-common-painkiller-21533&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21533,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21386
$metaTitle = &#039;LATEST NEWS UPDATES | Govt bans common painkiller&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The European Medicines Agency had recommended DPPP&#039;s withdrawal across the European Union in 2009, saying the drug&#039;s risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &amp;quot;It&#039;s truly heartening to hear the government has acted to ban this drug - better late than never,&amp;quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &amp;quot;We could only say - ask the government,&amp;quot; one doctor said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&amp;quot; one senior doctor in a government hospital said.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/govt-bans-common-painkiller-21533.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Govt bans common painkiller | Im4change.org</title>
    <meta name="description" content="
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Govt bans common painkiller</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><br />The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.</p><p align="justify">The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.</p><p align="justify">The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.</p><p align="justify">Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.</p><p align="justify">The European Medicines Agency had recommended DPPP's withdrawal across the European Union in 2009, saying the drug's risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.</p><p align="justify">Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &quot;It's truly heartening to hear the government has acted to ban this drug - better late than never,&quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.</p><p align="justify">Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.</p><p align="justify">When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &quot;We could only say - ask the government,&quot; one doctor said.</p><p align="justify">In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.</p><p align="justify">&quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&quot; one senior doctor in a government hospital said.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 21386,
		'title' => 'Govt bans common painkiller',
		'subheading' => '',
		'description' => '<div align="justify">
-The Telegraph
</div>
<p align="justify">
<br />
The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.
</p>
<p align="justify">
The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.
</p>
<p align="justify">
The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.
</p>
<p align="justify">
Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.
</p>
<p align="justify">
The European Medicines Agency had recommended DPPP's withdrawal across the European Union in 2009, saying the drug's risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.
</p>
<p align="justify">
Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &quot;It's truly heartening to hear the government has acted to ban this drug - better late than never,&quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.
</p>
<p align="justify">
Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.
</p>
<p align="justify">
When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &quot;We could only say - ask the government,&quot; one doctor said.
</p>
<p align="justify">
In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.
</p>
<p align="justify">
&quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&quot; one senior doctor in a government hospital said.
</p>',
		'credit_writer' => 'The Telegraph, 12 June, 2013, http://www.telegraphindia.com/1130612/jsp/nation/story_16998338.jsp#.UbgQpNjcjco',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'govt-bans-common-painkiller-21533',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 21533,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 21386,
	'metaTitle' => 'LATEST NEWS UPDATES | Govt bans common painkiller',
	'metaKeywords' => 'medicines,Health',
	'metaDesc' => '
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug...',
	'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br />The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.</p><p align="justify">The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.</p><p align="justify">The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.</p><p align="justify">Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.</p><p align="justify">The European Medicines Agency had recommended DPPP's withdrawal across the European Union in 2009, saying the drug's risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.</p><p align="justify">Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &quot;It's truly heartening to hear the government has acted to ban this drug - better late than never,&quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.</p><p align="justify">Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.</p><p align="justify">When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &quot;We could only say - ask the government,&quot; one doctor said.</p><p align="justify">In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.</p><p align="justify">&quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&quot; one senior doctor in a government hospital said.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 21386,
	'title' => 'Govt bans common painkiller',
	'subheading' => '',
	'description' => '<div align="justify">
-The Telegraph
</div>
<p align="justify">
<br />
The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.
</p>
<p align="justify">
The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.
</p>
<p align="justify">
The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.
</p>
<p align="justify">
Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.
</p>
<p align="justify">
The European Medicines Agency had recommended DPPP's withdrawal across the European Union in 2009, saying the drug's risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.
</p>
<p align="justify">
Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &quot;It's truly heartening to hear the government has acted to ban this drug - better late than never,&quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.
</p>
<p align="justify">
Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.
</p>
<p align="justify">
When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &quot;We could only say - ask the government,&quot; one doctor said.
</p>
<p align="justify">
In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.
</p>
<p align="justify">
&quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&quot; one senior doctor in a government hospital said.
</p>',
	'credit_writer' => 'The Telegraph, 12 June, 2013, http://www.telegraphindia.com/1130612/jsp/nation/story_16998338.jsp#.UbgQpNjcjco',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'govt-bans-common-painkiller-21533',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 21533,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 21386
$metaTitle = 'LATEST NEWS UPDATES | Govt bans common painkiller'
$metaKeywords = 'medicines,Health'
$metaDesc = '
-The Telegraph



The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.


The health ministry, in a drug...'
$disp = '<div align="justify">-The Telegraph</div><p align="justify"><br />The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage.</p><p align="justify">The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available.</p><p align="justify">The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP.</p><p align="justify">Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine.</p><p align="justify">The European Medicines Agency had recommended DPPP's withdrawal across the European Union in 2009, saying the drug's risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses.</p><p align="justify">Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. &quot;It's truly heartening to hear the government has acted to ban this drug - better late than never,&quot; Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph.</p><p align="justify">Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent.</p><p align="justify">When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. &quot;We could only say - ask the government,&quot; one doctor said.</p><p align="justify">In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold.</p><p align="justify">&quot;It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents,&quot; one senior doctor in a government hospital said.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Govt bans common painkiller

-The Telegraph The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage. The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans and safer alternatives are available. The notification, issued on May 23, comes nearly four years after Indian doctors had warned that the drug has a high addictive potential and documented a disproportionately high rate of epileptic seizures among patients abusing DPPP. Several pharmaceutical companies in India manufacture DPPP that is sold under different brand names and is primarily used in the treatment of mild or moderate pain. Some companies also sell the drug in combination with other compounds such as paracetamol or dicyclomine. The European Medicines Agency had recommended DPPP's withdrawal across the European Union in 2009, saying the drug's risks, particularly the risk of a potential fatal overdose, are higher than its benefits. In 2010, the US Food and Drug Administration had banned the continued prescribing and use of DPPP after a study suggested it can lead to serious toxicity to the heart even when used at approved therapeutic doses. Doctors in India have also documented the addictive potential and associated adverse effects of DPPP, a weak opioid abused as a psychoactive substance by drug users who find it easier to procure such compounds than narcotics like heroin. "It's truly heartening to hear the government has acted to ban this drug - better late than never," Debasish Basu, a professor of psychiatry at the Post-Graduate Institute of Medical Education and Research, Chandigarh, told The Telegraph. Basu and his colleagues have documented both the addictive potential of DPPP and the incidence of epileptic seizures among drug addicts who had switched to DPPP. In a study published in 2009 in the American Journal on Addictions, Basu and his colleagues had analysed the case files of 312 patients with a history of DPPP abuse and observed that 63 patients (20 per cent) had suffered epileptic seizures that appeared related to their use of DPPP. In contrast, the rate of epileptic seizures among patients with a history of abuse of other opioid substances ranged between 0.4 per cent to 4 per cent. When the researchers presented their data on the addiction potential of DPPP and the high rates of epileptic seizures among DPPP abusers at an international conference in Australia, one participating delegate asked why the Indian government had not taken action to ban the drug. "We could only say - ask the government," one doctor said. In 1995, the health ministry had banned the manufacture and sale of combinations of DPPP with any other drug other than anti-spasmodic agents and non-steroidal anti-inflammatory agents. But products containing DPPP and paracetamol continued to be sold. "It is strange - paracetamol does not fall in the category of non-steroidal anti-inflammatory agents," one senior doctor in a government hospital said.